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The study of Pan and Shadel published in the premier 
issue of Aging further extends our understanding of the 
growing connection between the TOR pathway and 
mitochondrial function [1]. Interest in the TOR pathway 
for the aging community was initially spurred by a 
flurry of reports suggesting that in various model 
organisms, inhibition of this pathway could trigger 
lifespan extension [2-5]. In yeast, the TOR pathway 
regulates a number of diverse biological outcomes. For 
instance, treatment of S. cerevisiae with rapamycin, a 
highly specific TOR inhibitor, triggers cell cycle arrest, 
glycogen accumulation, increased autophagy, a global 
reduction in protein synthesis and sporulation. Adding 
to the complexity are the observations that in yeast as 
well as in mammalian cells, the TOR kinase exists in 
two separate multiprotein complexes. These complexes 
designated TORC1 and TORC2 have different biolo-
gical functions as well as different sensitivities to agents 
such as rapamycin. Further complicating the matter, in 
mammals there is a single TOR gene that functions in 
both the TORC1 and TORC2 complexes, while in S. 
cerevisiae there are two distinct TOR kinase genes.  
 
How does a reduction in TOR signaling lead to lifespan 
extension? Most evidence suggests that the TOR 
pathway is intimately linked to the sensing of nutrient 
status. In a simplified sense, TOR signaling is active 
when nutrients are abundant and inhibited during 
periods when food is scarce. Such observations have 
suggested a potential link between TOR activity and 
other well know strategies such as caloric restriction 
wherein limited food availability results in lifespan 
extension. While such links are on one level satisfying, 
the exact molecular connection between TOR activity 
and lifespan remains incompletely understood.   It  is  in  
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this context that the work of the Shadel laboratory is 
quite illuminating [1,6].  
 
As mentioned above, yeast have two TOR kinase genes. 
While Tor2p deletion is lethal, yeast without Tor1p are 
viable. Interestingly, these tor1Δ yeast strains are not 
only capable of surviving but actually have an increased 
chronological lifespan. Others have also observed that 
in yeast a decrease in TOR signaling resulted in lifespan 
extension, although these previous studies have 
implicated alterations in the stress resistance as the 
cause of this lifespan extension (5). In contrast, Shadel 
and colleagues have previously provided evidence that 
the increase in chronological life span seen in the tor1Δ 
yeast strains was intimately connected to a Tor-
dependent regulation of mitochondrial respiration [6]. 
Their data suggested that in yeast, mitochondrial 
respiratory capacity and ROS production was both 
sensed and regulated by the TOR pathway.  
 
In the current study, these past results linking yeast 
TOR to mitochondrial function have been significantly 
extended. A more detailed analysis of tor1Δ yeast 
strains have been performed especially with regard to 
the mitochondrial proteome. This new data suggests 
inhibition of TOR signaling results in an increase in the 
amount of mitochondrial oxidative phosphorylation 
(OXPHOS) subunits. This increase occurs at both the 
transcriptional and translational levels and involves both 
nuclear-encoded as well as mitochondrial-encoded 
subunits. Interestingly, this increase in OXPHOS 
subunits is not accompanied by an increase in the 
number of mitochondria, leading the authors to 
conclude that the net result is an increase in the density 
of OXPHOS subunits per mitochondria. How such 
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not entirely clear, although it is conceivable that more 
cytochrome elements per mitochondria in turn leads to 
more overall mitochondrial respiration.  This would 
imply that under basal conditions, the number of 
cytochrome chains is rate limiting for respiration. 
Alternatively, it may be that the density of cytochromes 
in turn influences the formation of higher-order 
mitochondrial ‘supercomplexes’. These supercomplexes 
are known to contain multiple individual electron 
transport components and their formation and function 
are just beginning to be analyzed in detail [7,8]. 
 
Through proteomic analysis, the new study of Shadel 
and colleagues revealed that TOR inhibition led not 
only to an increase in OXPHOS components, but also to 
the increase in a number of other proteins that localize 
to the mitochondria. One particularly interesting 
upregulated protein is Yhb1p, a protein previously 
implicated in the detoxification of nitric oxide. While 
there are no previous links between TOR activity and 
NO biology, there is an extensive literature suggesting 
that nitric oxide can regulate mitochondrial function 
[9,10]. Furthermore, mouse models have demonstrated 
a prominent role for NO in mediating the increase in 
mitochondrial number observed in the setting of caloric 
restriction [11,12]. Given the known role of the TOR 
pathway in potentially mediating the lifespan extending 
effects of low nutrients, this new proteomic connection 
to nitric oxide homeostasis is particularly intriguing.  
 
Where do these current results leave us with regard to 
mammalian aging and the role of TOR in regulating 
mitochondrial metabolism? Accumulating evidence 
suggests that mTOR can also regulate mitochondrial 
number and function in mammalian cells [13,14]. 
Similarly, proteomic analysis of human T cells treated 
with rapamycin has demonstrated alteration in 
OXPHOS components including cytochrome c oxidase 
and ATP synthase [15]. These same electron transport 
components were also observed to be altered by Shadel 
and colleagues in their yeast system. Nonetheless, while 
TOR activity seems to be important in regulating 
mitochondrial function in both systems, the emerging 
data suggest that in yeast, TOR inhibition activates 
mitochondrial function. In contrast, similar inter-
ventions in mammalian cells appear to reduce 
mitochondrial function. These observed differences in 
the direction of TOR regulation of mitochondrial 
activity complicates any straightforward unifying 
hypothesis regarding how increased or decrease in TOR 
activity might alter lifespan in both yeast and mammals.  
It is important to realize however, that when grown in 
glucose media, yeast cells preferentially metabolize this 
six carbon sugar to ethanol. It is only when the media 
becomes depleted of fermentable carbon that yeast cells 
undergo what as known as the diauxic shift, and begin 
to metabolize ethanol through an oxygen and mito-
chondrial dependent pathway.  In contrast, under resting 
conditions, mammalian cells are usually much more 
heavily dependent on mitochondrial respiration to meet 
their ongoing energetic needs. Thus, the role of basal 
mitochondrial respiration is very different in yeast 
versus mammalian cells. Understanding and exploring 
these differences will undoubtedly provide important 
insight into the growing interconnection of TOR, 
mitochondria and the rate of living.   
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